Yargesa
Capsule, hard
Compare
|
EU/1/17/1176/001
Authorised: 22/03/2017
Piramal Critical Care B.V.
|
SPC
PIL
IPAR
|
Yasmin 0.03 mg / 3 mg film-coated tablets
Film-coated tablet
Compare
|
PA1410/023/001
Authorised: 27/10/2000
Bayer Limited
|
SPC
PIL
EdM
|
Yasminelle 0.02 mg/3 mg film-coated tablets
Film-coated tablet
Compare
|
PA1410/024/001
Authorised: 24/07/2006
Bayer Limited
|
SPC
PIL
EdM
|
Yaz 0.02 mg/3 mg film-coated tablets
Film-coated tablet
Compare
|
PA1410/056/001
Authorised: 17/10/2008
Bayer Limited
|
SPC
PIL
EdM
|
Yellox
Eye drops, solution
Compare
|
EU/1/11/692/001
Authorised: 18/05/2011
Bausch Health Ireland Limited
|
SPC
PIL
IPAR
|
Yentreve
Gastro-resistant capsule, hard
Generics List:
Duloxetine 20mg Gastro-Resistant Capsules
Compare
|
EU/1/04/280/001
Eli Lilly Nederland B.V.
|
SPC
PIL
IPAR
|
Yentreve
Gastro-resistant capsule, hard
Generics List:
Duloxetine 40mg Gastro-Resistant Capsules
Compare
|
EU/1/04/280/1-6
Eli Lilly Nederland B.V.
|
SPC
PIL
IPAR
|
Yervoy
Concentrate for solution for infusion
Compare
|
EU/1/11/698/001-002
Bristol-Myers Squibb Pharma EEIG
|
SPC
PIL
IPAR
EdM
|
Yesafili
Solution for injection
Compare
|
EU/1/23/1751/001-002
Authorised: 15/09/2023
Biosimilar Collaborations Ireland Limited
|
SPC
PIL
IPAR
|
YESCARTA
Dispersion for infusion
Compare
|
EU/1/18/1299/001
Authorised: 23/08/2018
Kite Pharma EU B.V.
|
SPC
PIL
IPAR
EdM
|
Yondelis
Powder for concentrate for solution for infusion
Compare
|
EU/1/07/417/2
Authorised: 17/09/2007
Pharma Mar S.A.
|
SPC
PIL
IPAR
|
Yondelis
Powder for concentrate for solution for infusion
Compare
|
EU/1/07/417/1
Authorised: 17/09/2007
Pharma Mar S.A.
|
SPC
PIL
IPAR
|
Yorvipath
Solution for injection in pre-filled pen
Compare
|
EU/1/23/1766/001
Authorised: 17/11/2023
Ascendis Pharma Bone Diseases A/S
|
SPC
PIL
IPAR
|
Yorvipath
Solution for injection in pre-filled pen
Compare
|
EU/1/23/1766/002
Authorised: 17/11/2023
Ascendis Pharma Bone Diseases A/S
|
SPC
PIL
IPAR
|
Yorvipath
Solution for injection in pre-filled pen
Compare
|
EU/1/23/1766/003
Authorised: 17/11/2023
Ascendis Pharma Bone Diseases A/S
|
SPC
PIL
IPAR
|
Yselty 100 mg film-coated tablets
Film-coated tablet
Compare
|
EU/1/21/1606/001
Authorised: 14/06/2022
Theramex Ireland Limited
|
SPC
PIL
IPAR
|
Yselty 200 mg film-coated tablets
Film-coated tablet
Compare
|
EU/1/21/1606/002
Authorised: 14/06/2022
Theramex Ireland Limited
|
SPC
PIL
IPAR
|
Yttriga
Radiopharmaceutical precursor, solution
Compare
|
EU/1/05/322/001
Authorised: 19/01/2006
Eckert & Ziegler Radiopharm GmbH
|
SPC
PIL
IPAR
|
Yuflyma
Solution for injection
Compare
|
EU/1/20/1513/017
Authorised: 15/11/2023
Celltrion Healthcare Hungary Kft.
|
SPC
PIL
IPAR
|
Yuflyma
Solution for injection
Compare
|
EU/1/20/1513/001-012
Authorised: 11/02/2021
Celltrion Healthcare Hungary Kft.
|
SPC
PIL
IPAR
EdM
|